# Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/semaglutide-once-weekly-as-add-on-to-sglt-2-inhibitor-therapy-in-type-2-diabetes/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Bernard Zinman,Vaishali Bhosekar,Robert S. Busch,Ingrid Holst,Bernhard Ludvik,Desirée Thielke,James Thrasher,Vincent Woo,Athena Philis‐Tsimikas |
| Citations | 374 |
| DOI | 10.1016/s2213-8587(19)30066-x |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2918407168 |
| PMID | 30833170 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Bernard Zinman](https://scholariq.org/researchers/bernard-zinman/)
- [Bernhard Ludvik](https://scholariq.org/researchers/bernhard-ludvik/)
- [Robert S. Busch](https://scholariq.org/researchers/robert-s-busch/)

## Paper journal

- [The Lancet Diabetes & Endocrinology](https://scholariq.org/journals/the-lancet-diabetes-and-endocrinology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.